Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 20 | 0 | 2 | 0 | €105.78 | €116.25 | 9.896% |
| AbbVie Inc. | 34 | 0 | 2 | 0 | €179.26 | €181.45 | 1.220% |
| Abeona Therapeutics Inc. | 6 | 1 | 2 | 0 | €5.20 | €13.84 | 166.237% |
| Acadia Healthcare | 1 | 0 | 0 | 0 | €69.00 | - | - |
| Acadia Pharmaceuticals | 35 | 1 | 0 | 0 | €14.62 | €29.92 | 104.620% |
| AC Immune Ltd | 4 | 0 | 1 | 0 | €2.78 | €8.68 | 212.620% |
| Addus Homecare Corp. | 24 | 1 | 1 | 0 | €112.00 | €119.56 | 6.750% |
| Adverum Biotechnologies Inc. | 10 | 0 | 2 | 0 | €1.38 | €25.32 | 1734.529% |
| Affimed N.V. | 11 | 6 | 2 | 0 | €0.55 | €9.22 | 1567.089% |
| Agilent Technologies Inc. | 16 | 5 | 3 | 1 | €124.46 | €134.50 | 8.068% |
| Agios Pharmaceuticals Inc. | 9 | 1 | 0 | 0 | €40.60 | €48.75 | 20.072% |
| Akebia Therapeutics Inc. | 6 | 2 | 1 | 0 | €1.34 | €4.60 | 243.134% |
| Akero Therapeutics Inc | 17 | 0 | 0 | 0 | €23.75 | €38.19 | 60.815% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €5.19 | - | - |
| Alkermes plc | 17 | 2 | 0 | 0 | €24.20 | €35.01 | 44.683% |
| Allscripts Healthcare | 2 | 0 | 0 | 0 | €8.00 | €11.95 | 49.394% |
| Alnylam Pharmace. | 48 | 1 | 5 | 1 | €227.40 | €270.99 | 19.169% |
| Amedisys Inc. | 11 | 0 | 0 | 0 | €86.50 | €92.26 | 6.659% |
| Amgen Inc. | 28 | 0 | 0 | 0 | €294.30 | €304.82 | 3.574% |
| Amicus Therapeutics Inc. | 9 | 0 | 2 | 0 | €10.40 | €17.63 | 69.538% |
| Amneal Pharmaceuticals Inc | 1 | 0 | 0 | 0 | €7.60 | €10.00 | 31.579% |
| AnaptysBio Inc | 12 | 0 | 2 | 0 | €32.20 | €48.09 | 49.339% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €22.00 | €28.29 | 28.594% |
| arGEN X BV | 1 | 0 | 0 | 0 | €481.40 | €470.00 | -2.368% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €106.00 | €150.00 | 41.509% |